BDKRB2 and stroke disorder: In addition, intravenous injection or overexpression of tissue kallikrein (able to generate kallidin, a bradykinin analog, after cleavage of low-molecular kininogen) has beneficial effects in stroke, which are dependent on B2R activation (54, 55).